Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97%
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panacea Biotec Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Income from Continuing Operations
-â‚ą153.7m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Income from Continuing Operations
-â‚ą184.8m
CAGR 3-Years
-79%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Income from Continuing Operations
-â‚ą2.6m
CAGR 3-Years
71%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Income from Continuing Operations
â‚ą66.6m
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Income from Continuing Operations
â‚ą262.9m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Income from Continuing Operations
â‚ą18.7B
CAGR 3-Years
36%
CAGR 5-Years
14%
CAGR 10-Years
15%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Income from Continuing Operations?
Income from Continuing Operations
-153.7m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Income from Continuing Operations amounts to -153.7m INR.

What is Panacea Biotec Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
58%

The average annual Income from Continuing Operations growth rates for Panacea Biotec Ltd have been 58% over the past three years .

Back to Top